{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:39:34Z","timestamp":1782103174700,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004785","name":"Nordforsk","doi-asserted-by":"publisher","award":["105572"],"award-info":[{"award-number":["105572"]}],"id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126870","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:19:28Z","timestamp":1740068368000},"page":"126870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0693-3851","authenticated-orcid":false,"given":"Fanny","family":"Bergstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9228-7357","authenticated-orcid":false,"given":"Tom","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126870_b1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: A mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2025.126870_b2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.28.2100563","article-title":"Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: Interim results of a living systematic review, 1 January to 14 May 2021","volume":"26","author":"Harder","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.126870_b3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.126870_b4","series-title":"Impact of COVID-19 vaccines on mortality in England: December 2020 to March 2021","author":"Andrews","year":"2021"},{"issue":"20","key":"10.1016\/j.vaccine.2025.126870_b5","article-title":"Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: A counterfactual analysis","volume":"17","author":"Ferreira","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2025.126870_b6","article-title":"Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan","volume":"28","author":"Kayano","year":"2022","journal-title":"Lancet Reg Heal West Pac"},{"issue":"49","key":"10.1016\/j.vaccine.2025.126870_b7","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1016\/j.vaccine.2022.10.007","article-title":"Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal","volume":"40","author":"Caetano","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126870_b8","doi-asserted-by":"crossref","first-page":"17762","DOI":"10.1038\/s41598-023-44942-6","article-title":"Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number","volume":"31","author":"Kayano","year":"2023","journal-title":"Sci Rep"},{"issue":"647","key":"10.1016\/j.vaccine.2025.126870_b9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9836","article-title":"Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence","volume":"14","author":"Gavish","year":"2022","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126870_b10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009098","article-title":"Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era","volume":"17","author":"Prem","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126870_b11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.aje.a116498","article-title":"Interpretation and estimation of vaccine efficacy under heterogeneity","volume":"136","author":"Halloran","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.126870_b12","series-title":"Covid-19 data portal","author":"Public Health Agency of Sweden","year":"2023"},{"issue":"49","key":"10.1016\/j.vaccine.2025.126870_b13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly Dec 3"},{"key":"10.1016\/j.vaccine.2025.126870_b14","series-title":"Estimating the fraction unreported covid-19 cases","author":"Public Health Agency of Sweden","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126870_b15","series-title":"The infection fatality rate of COVID-19 in Stockholm \u2013 Technical report","author":"Public Health Agency of Sweden","year":"2020"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2025.126870_b16","article-title":"Age-stratified infection fatality rate of COVID-19 in the non-elderly population","volume":"216","author":"Pezzullo","year":"2023","journal-title":"Environ Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126870_b17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285612","article-title":"Age-specific SARS-CoV-2 infection fatality rates derived from serological data vary with income and income inequality","volume":"18","author":"Rickards","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126870_b18","series-title":"Befolkningspyramid F\u00f6r Sverige","author":"Statistics Sweden","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126870_b19","series-title":"Estimated number of lives directly saved by COVID-19 vaccination programs in the WHO European region, December 2020 to March 2023","author":"The WHO European Respiratory Surveillance Network","year":"2024"},{"issue":"22","key":"10.1016\/j.vaccine.2025.126870_b20","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.vaccine.2021.04.002","article-title":"Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis","volume":"39","author":"Hogan","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126870_b21","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126870_b22","series-title":"Stan modeling language users guide and reference manual, 2.35","author":"Stan Development Team","year":"2023"},{"issue":"191","key":"10.1016\/j.vaccine.2025.126870_b23","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2022.0128","article-title":"Modelling preventive measures and their effect on generation times in emerging epidemics","volume":"19","author":"Favero","year":"2022","journal-title":"J R Soc Interface"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126870_b24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008892","article-title":"On realized serial and generation intervals given control measures: The COVID-19 pandemic case","volume":"17","author":"Torneri","year":"2021","journal-title":"PLoS Comput Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:30:17Z","timestamp":1750847417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":24,"alternative-id":["S0264410X25001677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126870","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.22.24312361","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126870"}}